Low-Dose Atropine for Treatment of Myopia

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

April 15, 2022

Study Completion Date

September 12, 2022

Conditions
Myopia
Interventions
DRUG

Atropine

Daily 0.01% atropine eyedrops

OTHER

Placebo Eyedrops

Daily placebo eyedrops

Trial Locations (13)

30322

The Emory Eye Center Dept of Ophthalmology, Atlanta

35294

University of Alabama at Birmingham, Birmingham

37232

Vanderbilt University Medical Center - Vanderbilt Eye Institute, Nashville

43205

Pediatric Ophthalmology Associates, Inc., Columbus

44514

Eye Care Associates, Inc., Poland

60415

Ticho Eye Associates, Chicago Ridge

60616

Illinois College of Optometry, Chicago

73104

Dean A. McGee Eye Institute, University of Oklahoma, Oklahoma City

77204

University of Houston College of Optometry, Houston

83702

St Luke's Hospital, Boise

84107

Rocky Mountain Eye Care Associates, Salt Lake City

97239

Casey Eye Institute, Portland

02453

Boston Children's Hospital Waltham, Boston

All Listed Sponsors
collaborator

Pediatric Eye Disease Investigator Group

NETWORK

collaborator

National Eye Institute (NEI)

NIH

lead

Jaeb Center for Health Research

OTHER